Can a Simple Beta-Blocker Improve Immunotherapy Responses?

A phase II trial examined propranolol's effect on adrenergic stress in esophageal cancer patients

Related Keywords

United States ,New York ,American ,Sarbajit Mukherjee ,Elizabeth Repasky ,Greg Laub ,American Society Of Clinical Oncology ,Roswell Park Comprehensive Cancer Center ,American Society ,Clinical Oncology ,Medpage Today ,Senior Director ,